Radiology in the lead: towards radiological profiling for precision medicine in glioblastoma patients? Editorial comment on Glioblastoma patients with a moderate vascular profile benefit the most from MGMT methylation

Bart Roelf Jan van Dijken*, A. van der Hoorn

*Corresponding author for this work

Research output: Contribution to journalEditorialAcademicpeer-review

Original languageEnglish
Number of pages2
JournalEuropean Radiology
Early online date11-Jan-2021
DOIs
Publication statusPublished - 11-Jan-2021

Keywords

  • TEMOZOLOMIDE

Cite this